Literature DB >> 32036158

Interobserver agreement of 18F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism.

Philippe Robin1, Ravinder K Grewal2, Pierre-Yves Le Roux3, Grégoire Le Gal4, Pierre-Yves Salaun5.   

Abstract

Entities:  

Year:  2020        PMID： 32036158      PMCID： PMC7437657          DOI： 10.1016/j.thromres.2020.01.028

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  9 in total

1.  Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Authors:  Patrick Reinartz; Franz-Josef Wieres; Wolfram Schneider; Alexander Schur; Ulrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

2.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Authors:  Dominique Delbeke; R Edward Coleman; Milton J Guiberteau; Manuel L Brown; Henry D Royal; Barry A Siegel; David W Townsend; Lincoln L Berland; J Anthony Parker; Karl Hubner; Michael G Stabin; George Zubal; Marc Kachelriess; Valerie Cronin; Scott Holbrook
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

3.  Utility of metabolic heterogeneity factor in differentiating malignant versus benign parotid uptake on 18F FDG PET-CT.

Authors:  Ramin Alipour; Steven Smith; Sandeep K Gupta
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

4.  Good clinical practice recommendations for the use of PET/CT in oncology.

Authors:  Pierre-Yves Salaün; Ronan Abgral; Olivier Malard; Solène Querellou-Lefranc; Gilles Quere; Myriam Wartski; Romain Coriat; Elif Hindie; David Taieb; Antoine Tabarin; Antoine Girard; Jean-François Grellier; Isabelle Brenot-Rossi; David Groheux; Caroline Rousseau; Désirée Deandreis; Jean-Louis Alberini; Caroline Bodet-Milin; Emmanuel Itti; Olivier Casasnovas; Françoise Kraeber-Bodere; Philippe Moreau; Arnaud Philip; Corinne Balleyguier; Alain Luciani; Florent Cachin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-21       Impact factor: 9.236

5.  Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.

Authors:  Pierre-Yves Le Roux; Philippe Robin; Aurélien Delluc; Bernard Tardy; Ronan Abgral; Francis Couturaud; Abdelmalek Reffad; Grégoire Le Gal; Pierre-Yves Salaun
Journal:  Thromb Res       Date:  2014-10-20       Impact factor: 3.944

6.  Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.

Authors:  Ur Metser; Elka Miller; Hedva Lerman; Einat Even-Sapir
Journal:  AJR Am J Roentgenol       Date:  2007-11       Impact factor: 3.959

7.  Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.

Authors:  Philippe Robin; Pierre-Yves Le Roux; Benjamin Planquette; Sandrine Accassat; Pierre-Marie Roy; Francis Couturaud; Nadia Ghazzar; Nathalie Prevot-Bitot; Olivier Couturier; Aurélien Delluc; Olivier Sanchez; Bernard Tardy; Grégoire Le Gal; Pierre-Yves Salaun
Journal:  Lancet Oncol       Date:  2015-12-08       Impact factor: 41.316

Review 8.  Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.

Authors:  Nick van Es; Grégoire Le Gal; Hans-Martin Otten; Philippe Robin; Andrea Piccioli; Ramón Lecumberri; Luis Jara-Palomares; Piotr Religa; Virginie Rieu; Matthew Rondina; Mariëlle M Beckers; Paolo Prandoni; Pierre-Yves Salaun; Marcello Di Nisio; Patrick M Bossuyt; Harry R Büller; Marc Carrier
Journal:  Ann Intern Med       Date:  2017-08-22       Impact factor: 25.391

9.  Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.

Authors:  Philippe Robin; Pierre-Yves Le Roux; Karine Lacut; Benjamin Planquette; Nathalie Prévot-Bitot; Christian Lavigne; Jean Pastre; Adel Merah; Grégoire Le Gal; Pierre-Yves Salaun
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240
  9 in total
  1 in total

Review 1.  Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.

Authors:  Lindsay Robertson; Cathryn Broderick; Su Ern Yeoh; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2021-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.